Bringing together Stemwell’s regenerative medicine approach and DNA GTx’s genomic expertise to shape the future of personalized healthcare.
Obesity is one of the major health challenges of our time. More than a concern related to body weight, it is a complex, chronic condition influenced by genetics, metabolism, hormones, lifestyle, and environmental factors. It can affect multiple systems in the body and increase the risk of type 2 diabetes, cardiovascular disease, fatty liver disease, joint disorders, and other long-term health complications.
As our understanding of obesity evolves, healthcare is moving beyond a one-size-fits-all approach towards understanding the biological factors behind each individual’s condition. Regenerative medicine and genomics are two important fields contributing to this progress, offering new perspectives and potential future possibilities for addressing obesity through a better understanding of cellular health, genetic predisposition, and personalized healthcare.
Through the collaboration between Stemwell and DNA GTx, regenerative medicine and advanced genomic laboratory come together under a shared vision: making healthcare more personalized by considering each patient’s unique biology, health needs, and treatment goals.
Stemwell: Regenerative Medicine and Stem Cell Therapy
Obesity can place considerable stress on the body, contributing to chronic inflammation, increased pressure on joints, reduced mobility, and changes in tissue function. Addressing these associated health challenges is an important part of comprehensive obesity care.
Stemwell focuses on regenerative medicine and stem cells-based therapies designed to support cellular function, tissue health, and the body’s natural repair processes.
A key component of Stemwell’s approach is the use of mesenchymal stem/stromal cells (MSCs). According to Stemwell’s published information, its primary cell source is ethically sourced, donor-derived umbilical cord MSCs. Depending on the treatment protocol, these may also be combined with the patient’s own bone marrow-derived stem cells. MSCs are valued for their biological signaling and immunomodulatory properties, which may influence inflammatory responses and support tissue repair. [1]
Potential Applications for Obesity-Related Health Challenges
Regenerative medicine may be relevant to several associated health concerns that can affect individuals living with obesity:
- Joint health and mobility: Excess body weight can increase stress on weight-bearing joints. Stemwell's joint health programs address selected joint conditions and injuries, with the aim of supporting tissue health, reducing pain, and improving mobility.
- Inflammation and tissue health: IMSCs have immunomodulatory properties that may help influence inflammatory responses and support the body's tissue-repair processes.
- Chronic pain and physical function Stemwell's chronic conditions and pain-related programs provide cell-based approaches for selected conditions, with the goal of supporting physical function and quality of life.
- Healthy aging and vitality: Stemwell's longevity program focuses on cellular health and age-related changes as part of a broader approach to well-being.
These applications highlight an important aspect of obesity care: looking beyond body weight and considering the wider health needs of each individual. It is important to distinguish these applications from direct obesity treatment. Stem cell therapy is not an established treatment for obesity or a proven method for weight loss. Research into MSC-based approaches for metabolic complications, including insulin resistance and fatty liver disease, is ongoing, and further clinical evidence is needed to establish their safety and effectiveness for these conditions. [2,3]
DNA GTx: Understanding Obesity Through Genomics?
Every individual has a unique genetic profile that can influence appetite, satiety, energy balance, fat distribution, and susceptibility to metabolic conditions. Although most obesity results from interactions between multiple genes and environmental factors, genetic differences can help explain why individuals develop the condition differently and why their responses to treatment may vary.
This is where DNA GTx, Stemwell’s genomics partner, plays an important role.
Through advanced genomic and bioinformatics capabilities, including whole-genome sequencing and polygenic risk analysis, DNA GTx can help identify genetic variations and biological factors associated with individual health characteristics [4]. In obesity care, genomic insights may support:
- Genetic risk assessment: Identifying inherited predispositions associated with obesity and metabolic conditions.
- Understanding metabolic differences: Exploring genetic factors related to appetite regulation, energy balance, and metabolism.
- Personalized treatment planning: Providing additional information to help healthcare professionals consider individual characteristics when developing care strategies.
- Identifying genetic conditions: Supporting the assessment of rare genetic forms of obesity that may require specialist management.
By integrating genomic information into patient assessment, DNA GTx contributes to a more personalized approach, allowing healthcare professionals to consider more than symptoms alone. Genetic findings should always be interpreted alongside medical history, clinical assessments, and other relevant health information.
Connecting Regenerative Medicine and Precision Healthcare
The collaboration between Stemwell and DNA GTx brings together two complementary dimensions of modern healthcare. Genomics helps us understand the individual, while regenerative medicine focuses on cellular health and tissue function. Together, these approaches offer a broader perspective on patient needs and may help inform more individualized care strategies.
For people living with obesity, this means considering not only weight management but also associated complications, genetic predispositions, mobility, and overall health. Established approaches such as nutritional guidance, physical activity, appropriate medical treatment, and regular clinical monitoring remain essential. Emerging technologies can complement these approaches where clinically appropriate.
Innovation Looking Towards the Future
This World Obesity Day, the message is clear: the future of obesity care lies in understanding the individual behind the condition. Through regenerative medicine and its collaboration with DNA GTx, Stemwell is contributing to a more personalized approach to healthcare, bringing together cellular therapies and genomic insights to better understand patient needs and support informed treatment planning.
As science continues to advance, collaboration, responsible innovation, and evidence-based clinical practice will be essential in translating these developments into meaningful healthcare solutions. By looking beyond body weight and focusing on the biology of each individual, we can move towards a future where obesity care is more comprehensive, personalized, and patient-centred.
Speak to Stemwell today to find out more
Stem cell therapy represents an exciting new treatment avenue for hamstring injuries, with the potential to promote quicker healing and improve your overall quality of life. Our expert team at Stemwell are dedicated to supporting you and finding the right treatment option to meet your needs.
If you would like to find out more about stem cell therapy you can contact us with any questions, or apply today to check your eligibility.
References
1. Frequently Asked Questions: What type of stem cells does Stemwell use? Stemwell FAQ.
2. Zeng X, Cao J, Xin W, et al. Mesenchymal stromal cell-based therapies for obesity-associated metabolic complications: Mechanistic insights, translational evidence, and future perspectives. Biomedicine & Pharmacotherapy. 2026;204:119996. doi:10.1016/j.biopha.2026.119996.
3. Mikłosz A, Nikitiuk BE, Chabowski A. Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand? Obesity Reviews. 2022;23(5):e13413. doi:10.1111/obr.13413.
4. DNA GTx. Genomic Testing and Bioinformatics Solutions. DNA GTx official website.
5. How Precision Medicine Enhances Stem Cell Treatments. February 5, 2026